• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
EQRx, Inc. engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor, and Sugemalimab, an anti-programmed death-ligand 1 antibody.
Market Cap | 354.8 Million | Shares Outstanding | 40 Million | Avg 30-day Volume | 59.389 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | 0.18 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -157.3 Million |
Price to Book Value | 1.6815 | Operating Margin | 0.0 | Enterprise Value | 850.704 Million |
Current Ratio | 24.322 | EPS Growth | 0 | Quick Ratio | 23.929 |
1 Yr BETA | 0.2621 | 52-week High/Low | 11.52 / 8.58 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 0.0 | Altman Z-Score | 10.1851 | Free Cash Flow to Firm | 0 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
101,010 | 2022-09-30 | 1 | |
|
0 | 2021-12-17 | 0 | |
HEDRICK ERIC CHIEF PHYSICIAN EXECUTIVE |
|
0 | 2021-12-17 | 0 |
|
0 | 2021-12-17 | 0 | |
NALLICHERI MELANIE CHIEF EXECUTIVE OFFICER |
|
0 | 2021-12-17 | 0 |
RUBIN JAMI CHIEF FINANCIAL OFFICER |
|
0 | 2021-12-17 | 0 |
CASDIN ELI OFFICER (CEO) |
|
13,500,000 | 2021-08-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 22:15:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 21:45:04 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 21:15:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 20:45:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 20:15:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 19:45:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 19:15:04 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 18:45:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 18:15:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 17:45:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 17:15:03 UTC | -2.2674 | 2.3374 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 16:45:02 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 16:15:03 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 15:45:03 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 15:15:03 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 14:45:03 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 14:15:03 UTC | -2.173 | 2.243 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 13:45:03 UTC | -2.1589 | 2.2289 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 13:15:03 UTC | -2.1589 | 2.2289 | 100000 |
CM LIFE SCIENCES III INC CMLTU | 2021-12-17 12:45:04 UTC | -2.1589 | 2.2289 | 100000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|